Plus   Neg

TalkTalk Telecom Q1 Headline Revenue Up; Backs FY View For Strong EBITDA Growth

TalkTalk Telecom Group plc (TALK.L) reported Wednesday that its first-quarter headlines revenues increased, and trading was in line with expectations. Looking ahead, the company's fiscal 2020 guidance of strong EBITDA growth remains unchanged.

In its trading update for the 3 months to June 30, the company's total headline revenue, excluding Carrier and Off-net, grew 1.3% to 387 million pounds from 382 million pounds last year.

Headline On-net revenue, comprising Consumer, Wholesale and Direct B2B broadband, went up 2.6% from last year to 317 million pounds.

The on-net ARPU grew to 24.72 pounds from 24.65 pounds last year, with continued growth in Consumer ARPU.

The company recorded strong demand for Fibre with 118 thousand net adds in the quarter, up from 67 thousand last year.

For the full year, the company said it remains on track to deliver EBITDA in line with expectations, underpinned by accelerated Fibre penetration and cost reduction plans.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT